References
- Ablashi D. V., Lapps W., Kaplan M., Whitman J. E., Richert J. R., Pearson G.R. Human Herpesvirus-6 (HHV-6) Infection in Multiple Sclerosis: A Preliminary Report. Multiple Sclerosis 1998; 4, (in press)
- Albright A. V., Lavi E., Black J. B., Goldberg S., O'Conner M. J., Gonzalez-Scarano F. The Effect of Human Herpesvirus-6 (HHV-6) on Cultured Human Neural Cells: Oligodendrocytes and Microglia. NeuroVirology 1998; 4: 486–494
- Challoner P. B., Smith K. T., Parker J. D., MacLeod D. L., Coulter S. N., Rose T. M., Schultz E. R., Bennett J. L., Garber R. L., Chang M., Schad P. A., Stewart P. M., Nowinski R. C., Brown J. P., Burmer G C. Plaque-Associated Expression of Human Herpesvirus 6 in Multiple Sclerosis. Proc Natl Acad Sci 1995; 92: 7440–7444
- Dalgleish AG. Viruses and Multiple Sclerosis. Acta Neurol Scand 1997; S169: 8–15
- Garson J. A., Tuke P. W., Giraud P., Paranhos-Baccala G., Perron H. Detection of Virion-Associated MSRV-RNA in Serum of Patients with Multiple Sclerosis. Lancet 1998; 351: 33
- He J., McCarthy M., Zhou Y., Chandran B., Wood C. Infection of Primary Human Fetal Astrocytes by Human Herpesvirus 6. J Virol 1996; 70: 1296–1300
- Jacobson S. HTLV-I Myelopathy: An Immuno-pathologically Mediated Chronic Progressive Disease of The Central Nervous System. Current Opinion in Neurology 1995; 8: 179–183
- Johnson RT. The Virology of Demyelinating Diseases. Ann. Neurol 1994; 36: S54–S60
- Kimberlin D. W., Whitley R. J. Human Herpesvirus-6: Neurologic Implications of a Newly Described Viral Pathogen. NeuroVirology 1998; 4: 474–485
- Liedtke W., Malessa R., Faustmann P. M., Eis-Hubinger A. Human Herpesvirus 6 Polymerase Chain Reaction Findings in Human Immunodeficiency Virus Associated Neurological Disease and Multiple Sclerosis. J Neurovirol 1995; 1: 253–258
- Martin C. N., Gale C. R. The Epidemiology of Multiple Sclerosis. Acta Neurol Scand 1997; S169: 3–7
- McKenzie I.R.A., Carrigan D. R., Wiley C. A. Chronic Myelopathy Associated with Human Herpesvirus-6. Neurology 1995; 45: 2015–2017
- McCarthy M., Auger D., He J., Wood C. Cytomegalovirus and Human Herpesvirus-6 trans activate the HIV-1 Long Terminal Repeat Via Multiple Response Regions In Human Fetal Astrocytes. NeuroVirology 1998; 4: 495–511
- Nielsen L., Larsen A. M., Munk M., Vestergaard B. F. Human Herpesvirus 6 Immunoglobulin G Antibodies in Patients with Multiple Sclerosis. Acta Neurol Scand 1997; S169: 76–78
- Perron H., Garson J. A., Bedin F., Beseme F., Paranhos-Baccala G., Komurian-Pradel F., Mallet F., Tuke P. W., Voisset C., Blond J. L., LaLandes B., Seigneurin J. M., Mandrand B. Collaborative Research Group on Multiple Sclerosis Molecular Identification of A Novel Retrovirus Repeatedly Isolated From Patients with Multiple Sclerosis. Proc Natl Acad Sci USA 1997; 94: 7583–7588
- Sola P., Merelli E., Marasca R., Poggi M., Luppi M., Montorsi M., Torelli G. Human Herpesvirus 6 and Multiple Sclerosis: Survey of Anti-HHV-6 Antibodies by Immunofluorescence Analysis of Viral Sequences by Polymerase Chain Reaction. J Neurol Neurosurg Psych 1993; 56: 917–919
- Soldan S. S., Berti R., Salem N., Secchiero P., Calabressi P., Maloni H., McFarland H. F., Lin H., Patnaik M., Jacobson S. Association of Human Herpes Virus 6 (HHV-6) with Multiple Sclerosis: Increased IgM Response to HHV-6 Early Antigen and Detection of Serum HHV-6 DNA. Nature Medicine 1997; 3: 1394–1399
- Wilborn F., Schmidt C. A., Brinkman V., Jendroska K., Oettle H., Siegert W. A potential Role for Human Herpesvirus 6 in Nervous System Disease. J Neuroimmunol 1994; 49: 213–214